Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04922697
Other study ID # RG1121435
Secondary ID NCI-2021-0439910
Status Completed
Phase N/A
First received
Last updated
Start date September 15, 2021
Est. completion date March 5, 2022

Study information

Verified date July 2022
Source Fred Hutchinson Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial will conduct an educational intervention to promote knowledge of and preventive health behaviors related to personal air pollution exposure. Air pollution is n ubiquitous environmental exposure that is associated with harmful health effects including lung cancer. The educational intervention is comprised of 2 educational videos that include information regarding air pollution, health effects, and personal preventive health behaviors to reduce air pollution exposure and the use of a wearable air pollution sensor. The knowledge gained from this study may inform future research that will be designed to promote awareness of air pollution and its health effects.


Description:

OUTLINE: Participants watch 2 educational videos during week 3 regarding air pollution, health effects, and personal preventive health behaviors to reduce air pollution exposure. Participants complete questionnaires at weeks 1 and 5.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date March 5, 2022
Est. primary completion date January 10, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults 18 years or older: The evidence for personal strategies to reduce air pollution exposure has been focused on adults - Live in Seattle, WA: The study is designed to focus on Seattle, WA such as using EnviroFlash alerts - Own a smartphone: The participant requires a smartphone to setup the Flow app for the air pollution sensor - Not traveling in the near-term: The study is designed to assess air pollution patterns in the local Seattle area - Leave your home for at least 7 hours per week: Participants will use a wearable air pollution sensor to measure air pollutant levels from indoor and outdoor sources

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Educational Intervention
Watch educational videos and use wearable air pollution sensor
Questionnaire Administration
Complete questionnaires

Locations

Country Name City State
United States Fred Hutch/University of Washington Cancer Consortium Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
Fred Hutchinson Cancer Center Prevent Cancer Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in knowledge regarding air pollution Will calculate the proportion of the items that were answered correctly. McNemar's tests will be used to calculate differences in the proportion of participants answering air pollution knowledge items correctly at baseline and at week 5. At baseline and week 5
Primary Changes in air pollution preventive health behaviors Will calculate summary scores for air pollution preventive health behaviors and paired t-test to determine intervention effectiveness at baseline and at week 5. At baseline and week 5
Secondary Changes in perceived barriers Summary scores for perceived barriers (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived barriers at baseline and week 5. At baseline and week 5
Secondary Changes in perceived benefits Summary scores for perceived benefits (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived benefits at baseline and week 5. At baseline and week 5
Secondary Changes in perceived susceptibility Summary scores for perceived susceptibility (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived susceptibility at baseline and week 5. At baseline and week 5
Secondary Changes in perceived severity Summary scores for perceived severity (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived severity at baseline and week 5. At baseline and week 5
Secondary Changes in self-efficacy Summary scores for self-efficacy (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in self-efficacy at baseline and week 5. At baseline and week 5
Secondary Changes in cues to action Will calculate frequencies for each cue to action (guided by the Health Belief Model). McNemar's tests will be used to calculate differences in the proportion of participants regarding each cue to action at baseline and week 5. At baseline and week 5
Secondary Changes in air pollutant levels measured using the Flow 2 personal air quality sensor Paired t-tests will determine changes in air pollutant levels at baseline and week 2 vs. week 4 and week 5. At baseline and week 2 vs. week 4 and week 5
Secondary Intervention feasibility (accessibility) Will report descriptive statistics for intervention accessibility based on responses to the relevant questionnaire items at week 5. At week 5
Secondary Intervention feasibility (acceptability) Will report descriptive statistics for intervention acceptability based on responses to the relevant questionnaire items at week 5. At week 5
Secondary Intervention feasibility (demand) Will report descriptive statistics for intervention demand based on responses to the relevant questionnaire items at week 5. At week 5
Secondary Intervention feasibility (uptake, sensor upload completion) Will report descriptive statistics the proportion of participants completing sensor uploads. At baseline through week 5
Secondary Intervention feasibility (uptake, educational video viewing) Will report descriptive statistics for the proportion of viewing educational videos at week 3. At week 3
Secondary Intervention feasibility (uptake, questionnaire completion) Will report descriptive statistics for the proportion of completing the questionnaires at baseline and week 5. At baseline and week 5
See also
  Status Clinical Trial Phase
Recruiting NCT04931017 - Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer Phase 2
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Not yet recruiting NCT06038526 - Evaluation of Canakinumab in High-Risk Former-Smokers Phase 2
Terminated NCT02856581 - Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes Phase 3
Recruiting NCT04644952 - The Rise in Robotic Atypical Segmentectomies
Completed NCT01896778 - Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer N/A
Recruiting NCT05407168 - Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool N/A
Completed NCT04267874 - Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study Early Phase 1
Recruiting NCT02408861 - Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Phase 1
Recruiting NCT03709953 - Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma Phase 2
Active, not recruiting NCT03267524 - Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers N/A
Recruiting NCT04147494 - Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues Early Phase 1
Completed NCT02237183 - Iloprost in Preventing Lung Cancer in Former Smokers Phase 1
Recruiting NCT04783168 - Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study N/A
Completed NCT04635761 - Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening N/A
Active, not recruiting NCT03164486 - First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide Early Phase 1
Recruiting NCT05802186 - Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study N/A
Active, not recruiting NCT01696968 - Screening for Lung Cancer in Older Patients (PLCO Screening Trial) N/A
Recruiting NCT04410302 - Patient-Derived Xenografts to Reduce Cancer Health Disparities
Recruiting NCT04969341 - Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable Populations